Status: current, Defined. Date: 31-Jul 2011. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2735591000168112 | Gaviscon Aniseed oral liquid, 500 mL | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2735601000168117 | Gaviscon Aniseed (calcium carbonate 160 mg / 10 mL + sodium alginate 500 mg / 10 mL + sodium bicarbonate 267 mg / 10 mL) oral liquid, 500 mL (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Gaviscon Aniseed oral liquid, 500 mL | Is a | trade product pack | true | Inferred relationship | Some | ||
| Gaviscon Aniseed oral liquid, 500 mL | Is a | sodium alginate 500 mg/10 mL + sodium bicarbonate 267 mg/10 mL + calcium carbonate 160 mg/10 mL oral liquid, 500 mL | true | Inferred relationship | Some | ||
| Gaviscon Aniseed oral liquid, 500 mL | has TPUU | Gaviscon Aniseed oral liquid, 10 mL | true | Inferred relationship | Some | 1 | |
| Gaviscon Aniseed oral liquid, 500 mL | has TP | Gaviscon | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gaviscon Aniseed oral liquid, 500 mL, bottle | Is a | True | Gaviscon Aniseed oral liquid, 500 mL | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR